Showing results (1-10 of 296) with videos related to
Sort By:
Pageof 30
Seminars in Radiation Oncology|March 2, 2011
Will nanotechnology influence targeted cancer therapy?Jan Grimm, David A ScheinbergCurrent Opinion in Biotechnology|February 11, 2017
Advances in the clinical translation of nanotechnologyDavid A Scheinberg, Jan Grimm, Daniel A Heller, et al.Best Practice & Research. Clinical Haematology|September 16, 2008
Peptide vaccines for myeloid leukaemiasTao Dao, David A ScheinbergCurrent Radiopharmaceuticals|December 29, 2011
Actinium-225 in targeted alpha-particle therapeutic applicationsDavid A Scheinberg, Michael R McDevittCritical Reviews in Oncogenesis|October 2, 2014
Fibrillous carbon nanotube: an unexpected journeyMichael R McDevitt, David A ScheinbergOncoimmunology|September 28, 2013
Approaching untargetable tumor-associated antigens with antibodiesTao Dao, Cheng Liu, David A ScheinbergExpert Opinion on Biological Therapy|September 3, 2013
Therapeutic antibodies to intracellular targets in cancer therapyNicholas Veomett, Tao Dao, David A ScheinbergEuropean Journal of Nuclear Medicine and Molecular Imaging|January 19, 2024
Current clinical applications of Cerenkov luminescence for intraoperative molecular imagingNatalie Boykoff, Jan GrimmPediatric Radiology|December 4, 2010
Clinical applications in molecular imagingCarola Heneweer, Jan GrimmMolecular Pharmaceutics|December 10, 2025
Syntheses, Biological and Preclinical Evaluations, and Nanoparticle Formulations of the ROS-Activatable Prodrugs of Doxazolidine for Drug-Resistant Cancer TherapyRyo Tamura, Jan GrimmPageof 30